229 filings
8-K
MSLPQ
MusclePharm Corp
31 Aug 23
Departure of Directors or Certain Officers
5:23pm
8-K
MSLPQ
MusclePharm Corp
19 Jul 23
Departure of Directors or Certain Officers
3:06pm
8-K
MSLPQ
MusclePharm Corp
10 Mar 23
Departure of Directors or Certain Officers
4:16pm
8-K
MSLPQ
MusclePharm Corp
11 Jan 23
Bankruptcy or Receivership
5:02pm
8-K
MSLPQ
MusclePharm Corp
10 Jan 23
Changes in Registrant's Certifying Accountant
7:37pm
8-K
spm1ve
9 Jan 23
Bankruptcy or Receivership
2:41pm
8-K
d4v9az8f6fnqx
29 Sep 22
Departure of Directors or Certain Officers
4:33pm
8-K
397fc 4kdwt1zfzl
16 Sep 22
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
5:43pm
8-K
3o27316s5d wwowoswdp
23 Aug 22
Departure of Directors or Certain Officers
4:53pm
8-K
f8l5fm8bl2
22 Aug 22
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
5:09pm
8-K
ffkul1bqr7ahay
28 Jul 22
Departure of Directors or Certain Officers
4:30pm
8-K
muxbmp0br4 j5urb9
12 Jul 22
Departure of Directors or Certain Officers
5:00pm
8-K
7jbv3pnf irf49
22 Jun 22
Departure of Directors or Certain Officers
4:05pm
8-K
93qvxf b3fqx2
14 Jun 22
Entry into a Material Definitive Agreement
4:10pm
8-K
rqaquapdqn4
9 Jun 22
Entry into a Material Definitive Agreement
4:27pm
8-K
c7a0n
17 May 22
MusclePharm Announces First Quarter 2022 Financial Results
4:15pm
8-K
x1eg oojw574t8ubxi0
5 May 22
Company Delivers $10.0 Million of Net Revenue in Fourth Quarter 2021 and $50.0 Million of Net Revenue for Full Year 2021
4:55pm
8-K
5w79cp
28 Apr 22
MusclePharm Announces Fourth Quarter and Fiscal Year 2021 Financial Results
8:15am
8-K
jltxnrjo v34c34gt23
11 Mar 22
Entry into a Material Definitive Agreement
4:55pm
8-K
ko5fzuoc cqsoi82dpy
29 Dec 21
Departure of Directors or Certain Officers
4:04pm